Procaspase Activating Compound-1 (PAC-1) in the Treatment of Advanced Malignancies - Component 1
This study is currently recruiting participants.
Verified November 2017 by Oana Danciu, MD, University of Illinois at Chicago
Vanquish Oncology, Inc.
First Posted: February 4, 2015
Last Update Posted: November 20, 2017
University of Illinois at Chicago
Information provided by (Responsible Party):
Oana Danciu, MD, University of Illinois at Chicago
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study is currently recruiting participants.|
|Estimated Study Completion Date:||June 2018|
|Estimated Primary Completion Date:||March 2018 (Final data collection date for primary outcome measure)|